Roth Capital Resumes Neogenomics (NEO) at Buy
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $13.85 --0%
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Join SI Premium – FREE
Roth Capital resumed coverage on Neogenomics (NASDAQ: NEO) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.
Shares of Neogenomics closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Napco Security Technologies, Inc. (NSSC) at Buy
- Morgan Stanley Upgrades EPAM Systems (EPAM) to Equalweight
- RBC Capital Downgrades Range Resources (RRC) to Sector Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
